NCT05035732 2024-01-18A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)M.D. Anderson Cancer CenterPhase NA Withdrawn